Rinvoq ER 15 MG tablet UU 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6Y1M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,492
Award facts
- Contract value 100% obligated
- $17,491.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,491.63 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 MG tablets (30-count units) on January 27, 2026, with an ultimate completion date of January 28, 2026. This firm fixed-price delivery order is issued without a set-aside designation, reflecting competitive procurement on a full and open basis. The work will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc., a leading pharmaceutical distribution company that serves as a critical vendor to federal military and veteran healthcare systems.
This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This comprehensive IDC serves as a global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and specialized medical supplies. The DLA Troop Support's strategic approach involves establishing multiple regional contracts with different contractors, demonstrating AmerisourceBergen's continued role in supporting military treatment facilities, the Defense Health Agency, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DR26F6Y1M?
SPE2DR26F6Y1M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26F6Y1M worth?
The government has obligated $17,492 on SPE2DR26F6Y1M.
Is contract SPE2DR26F6Y1M an order under another contract?
Yes. SPE2DR26F6Y1M is a delivery order under SPE2DR25D3013, an indefinite delivery contract.
Was contract SPE2DR26F6Y1M competed?
The extent of competition for SPE2DR26F6Y1M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award